Patents by Inventor Farideh Afshin Javid

Farideh Afshin Javid has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS COMPRISING CANNABINOIDS FOR TREATMENT OF NAUSEA, VOMITING, EMESIS, MOTION SICKNESS OR LIKE CONDITIONS
    Publication number: 20200206151
    Abstract: Cannabinoids, in particular CBD and CBDA and their acid derivatives are provided for use as an active pharmaceutical substance in the treatment of nausea, vomiting, emesis, motion sickness. In particular extracts of cannabis plants are presented which are rich in these substances and suitable for pharmaceutical use.
    Type: Application
    Filed: August 6, 2019
    Publication date: July 2, 2020
    Applicant: GW Pharma Limited
    Inventors: BRIAN ANTHONY WHITTLE, Farideh Afshin Javid
  • Use of phytocannabinoids in the treatment of ovarian carcinoma
    Patent number: 10098867
    Abstract: The present invention relates to the use of phytocannabinoids in the treatment of ovarian cancer. Preferably the phytocannabinoid is selected from the group consisting of: cannabidiol (CBD); cannabidiol acid (CBDA); cannabigerol (CBG); cannabigerolic acid (CBGA); cannabigerol propyl variant (CBGV); and tetrahydrocannabivarin (THCV). In a further embodiment the one or more phytocannabinoids are used in combination with each other. Preferably the combination of cannabinoids consists of CBD and CBG.
    Type: Grant
    Filed: June 19, 2014
    Date of Patent: October 16, 2018
    Assignee: GW Research Limited
    Inventors: Farideh Afshin Javid, Marnie Duncan, Colin Stott
  • COMPOSITIONS COMPRISING CANNABINOIDS FOR TREATMENT OF NAUSEA, VOMITING, EMESIS, MOTION SICKNESS OR LIKE CONDITIONS
    Publication number: 20170079933
    Abstract: Cannabinoids, in particular CBD and CBDA and their acid derivatives are provided for use as an active pharmaceutical substance in the treatment of nausea, vomiting, emesis, motion sickness. In particular extracts of cannabis plants are presented which are rich in these substances and suitable for pharmaceutical use.
    Type: Application
    Filed: September 28, 2016
    Publication date: March 23, 2017
    Applicant: GW Pharma Limited
    Inventors: Brian Anthony Whittle, Farideh Afshin Javid
  • COMPOSITIONS COMPRISING CANNABINOIDS FOR TREATMENT OF NAUSEA, VOMITING, EMESIS, MOTION SICKNESS OR LIKE CONDITIONS
    Publication number: 20120059062
    Abstract: Cannabinoids, in particular CBD and CBDA and their acid derivatives are provided for use as an active pharmaceutical substance in the treatment of nausea, vomiting, emesis, motion sickness. In particular extracts of cannabis plants are presented which are rich in these substances and suitable for pharmaceutical use.
    Type: Application
    Filed: August 31, 2011
    Publication date: March 8, 2012
    Applicant: GW Pharma Limited
    Inventors: Brian Whittle, Farideh Afshin Javid
  • Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions
    Patent number: 8034843
    Abstract: Cannabinoids, in particular CBD and CBDA and their acid derivatives are provided for use as an active pharmaceutical substance in the treatment of nausea, vomiting, emesis, motion sickness. In particular extracts of cannabis plants are presented which are rich in these substances and suitable for pharmaceutical use.
    Type: Grant
    Filed: February 3, 2003
    Date of Patent: October 11, 2011
    Assignee: GW Pharma Limited
    Inventors: Brian Whittle, Farideh Afshin Javid